The Information in this section is intended for healthcare professionals only.

Please confirm that you are a healthcare professional.


This site uses cookies for site interaction analysis with a purpose of service quality enhancing and uninterrupted site work. More details in Cookies Policy


Lipid-lowering medications. HMG-CoA reductase inhibitors. Rosuvastatin.

Treatment of hypercholesterolemia For adults and children over 10 years of age with primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (type IIb) as an adjunct to the diet when the diet and the use of other non-drug products (e.g. exercise, weight loss) are insufficient. In homozygous familial hypercholesterolemia as an adjunct to the diet and other lipid-lowering treatments (e.g., LDL apheresis) or when such treatment is inappropriate. Prevention of cardiovascular disorders Prevention of significant cardiovascular disorders in patients at high risk of the first case of cardiovascular disorders, as an adjunct to the correction of other risk factors.

Release form Indivisible tablet
Pregnant Contraindicated
Lactating (Period of breast feeding) Contraindicated
Category of release Prescription only medicine
Diabetics With caution
With alcohol With caution
Storage temperature not higher than 25 °С
Instruction is available only in ukrainian
Instruction for medical use
Specialized edition for medical institutions and doctors.